 The hope was to reverse damaged and diseased tissue in Parkinsons patients and overall slow the progression of the disease.However, results were inconclusive and showed that while the drug appears to be relatively safe, there was no statistically significant data supporting the improvement of motor function or neuronal health.Neurturin’s therapeutic potential is unknown and future studies aim to improve delivery of the drug.